Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
Table 1
Baseline characteristics, 6-month and 12-month follow-up data of 155 morbidly obese patients who underwent Roux-en-Y gastric bypass surgery.
Baseline
6 months
12 months
for trend
Gender (women/men)
108/47
—
—
—
Age (years)
45.5 (11.0)
—
—
—
Height (cm)
169.4 (8.8)
168.8 (8.4)
168.7 (8.5)
NS
Weight (kg)
126.0 (21.4)
93.9 (17.0)
89.3 (18.4)
<0.001
BMI (kg/m2)
43.7 (6.3)
32.7 (5.0)
31.3 (5.8)
<0.001
Sagittal diameter (cm)
32.6 (3.9)
24.1 (3.4)
23.2 (4.2)
<0.001
B-Hb (g/l)
143 (11.1)
140 (11.3)
138 (10.5)
<0.001
CRP (mg/l)
7.6 (4.3)
5.2 (1.6)
5.4 (2.1)
<0.001
Platelets counts (x109/l)
302 (70)
268 (69)
255 (61)
<0.001
P-glucose (mmol/l)
7.5 (2.9)
5.7 (1.0)
5.8 (1.5)
<0.001
HbA1c (mmol/mol)
47.5 (15.6)
37.6 (8.2)
36.9 (8.9)
<0.001
P-ApoB/ApoA1
0.71(0.20)
0.55 (0.17)
0.52 (0.15)
<0.001
P-triglycerides (mmol/l)
2.01 (1.25)
1.27 (0.59)
1.16 (0.56)
<0.001
S-25-OH-vit D (nmol/l)
48.8 (17.1)
64.1 (19.5)
65.3 (21)
<0.001
P-parathormone (pmol/l)
7.8 (2.1)
7.5 (4.1)
8.0 (5.6)
NS
S-calcium (mmmol/l)
2.30 (0.09)
2.34 (0.08)
2.33 (0.09)
NS
P-magnesium (mmol/l)
0.80 (0.06)
0.82 (0.06)
0.82 (0.06)
<0.001
P-ALT (μkat/l)
0.74 (0.34)
0.63 (0.26)
0.65 (0.40)
<0.001
P-GGT (μkat/l)
0.71 (0.46)
0.43 (0.49)
0.44 (0.51)
<0.001
SBP (mmHg)
135.8 (18.7)
126.2 (16.6)
129.0 (14.9)
<0.001
DBP (mmHg)
81.6 (10.3)
77.1 (9.9)
77.1 (10.1)
<0.001
Data shown are arithmetic means (±SD). BMI: body mass index, CRP: C-reactive protein, GGT: gamma-glutamyltransferase, ALT: alanine aminotransferase, SBP: systolic blood pressure, and DPP: diastolic blood pressure. P: plasma and S: serum.
